How many drugs treat Organic Cardiac Disease?

Drug Landscape tracks 2 marketed treatments for Organic Cardiac Disease (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/organic-cardiac-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Organic Cardiac Disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Organic Cardiac Disease (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Organic Cardiac Disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Dobutamine Hydrochloride In Dextrose 5% In Plastic Container	Dobutamine Hydrochloride	Pfizer Inc.	Inotropic agent	Beta-receptors of the heart		1978-01-01
Dobutamin	Dobutamin	Competence Network for Congenital Heart Defects		Solute carrier family 22 member 1, Alpha-1D adrenergic receptor, Alpha-2B adrenergic receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Organic Cardiac Disease
Competence Network for Congenital Heart Defects · 1 drug in Organic Cardiac Disease
Pfizer Inc. · 1 drug in Organic Cardiac Disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Organic Cardiac Disease:

Cite this brief

Drug Landscape (2026). Organic Cardiac Disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/organic-cardiac-disease. Accessed 2026-06-10.

Organic Cardiac Disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing